Researchers have suggested that uniform evidence standards and reporting requirements could help speed patient access to cell ...

"We just cannot take this," one scientist said, as UMass Chan Medical School stands to lose about $41 million in annual ...

Drug development is an expensive and high-risk process. The median cost per approved drug can reach up to $2.8 billion, ...

During a Case-Based Roundtable® event, Natalie Galanina, MD, discussed data from the ZUMA-7 and TRANSFORM trials in the first ...

Bantam Pharmaceutical, a drug discovery and development company targeting selective modulation of mitochondrial dynamics in ...

Vodafone has tested using drones equipped with special light beams to temporarily reconnect mobile phone masts after the ...

NYU Langone has built an LLM research companion and medical advisor, and is pioneering what it calls AI-driven “precision medical education." ...

Insights from Prothena's Q4 2024 call highlight 2025 milestones: pivotal trial results for birtamimab & Alzheimer's programs.

Broadband ISP and mobile operator Vodafone has revealed that they've begun "piloting" (no pun intended, we think) a new type ...

Exact Sciences has a multipronged approach to cancer testing. Current products are Cologuard, its flagship stool-based screening test for colorectal cancer, or CRC, and Oncotype DX, its tissue-based ...